Oncogene addiction

نویسنده

  • Jeffrey Settleman
چکیده

to begin with and be bloody-minded about continuing this specific interest. You should always enjoy biology, even when some aspects of doing research are tedious or even unsuccessful. If you don’t enjoy what you are doing, then you might as well be in business and be paid well to do boring things! Beyond that it is a matter of personal style; my advice depends upon where you are on the personality gradient between risk-adverse and risk-prone, and how comfortable you are with the unpredictable. At one extreme, if you are (like me) more risk-prone, you should be extremely exploratory, daring, and original in the scientific questions you ask and do research on. Do ‘interesting’ science rather than ‘important’ science. This is more likely to yield significant new discoveries because few people have addressed supposedly ‘unimportant’ questions. The history of science suggests that almost no major discoveries were done because that research topic was ‘important’ at that time. There is a bigger risk to your career in going for interesting science for three reasons: you might get into an intellectual cul-de-sac, so you need to learn how to recognize dead ends; it is much harder to get funding for really original or ‘unimportant’ science; you need to have thorough knowledge which cuts across several scientific fields, which takes longer and requires more effort. You will also have to learn how to recognize completely new phenomena. Don’t get caught in intellectual ruts caused by excessive reading of the literature, but do be careful to ensure that you give all credit to all published work. Let natural phenomena be your guide rather than the literature if you want to make really new discoveries. At the other extreme, if you are risk-adverse, then stick to ‘important’ and applied science or technology, it is far easier because questions are well-defined and funding is easy, and its easy to churn out papers making tiny advances, so your career will advance quickly. But the risk is that you won’t make any significant contribution to science and your name will be forgotten after you go into administration because tiny advances are not satisfying, or retire, rich. As you can see, where you sit on the gradient is a matter of taste and style, but don’t forget your original goals! What do you think of the worldwide trend in research councils and foundations towards more and more applied research at the expense of ‘pure’ research? I am worried by this trend. It is presumably driven by the fact that research councils and foundations have to justify spending money to their governments and boards, and it is difficult to sustain funding if it seems ‘unimportant’ or even ‘useless’. Very few people controlling research funding realize that breakthroughs in science are like a tree giving off thousands of seeds of which only a few germinate. As a result, the people in councils have to favor ‘important’ science, and researchers have to stretch descriptions of basic research to sound as though it has significant applied implications. This is terrible, for two reasons. First it inhibits genuine exploratory (‘blue sky’) research, hence greatly reduces the probability of genuinely new discoveries and concepts. Second, and positively dangerous, the constant exaggerated description of all research projects having supposedly significant applied outcomes is constantly raising the expectations of the public. As this gets worse and worse expectations rise and failures become more frequent, and public confidence in science declines. This is the classical problem of short-term gains at the expense of long-term survival. Pretending all science has immediate beneficial applications results in long term destruction of support for and interest in science. Right now we are just depending upon sheer numbers of researchers stumbling on new phenomena in a social atmosphere of rapidly declining confidence in science because we are constantly raising expectations. Somebody needs to write a popular book about the cultural/social environment that has favored major scientific breakthroughs in the past, and how this needs to be encouraged. We risk the long-term survival of science by not letting the public know how science really proceeds.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Oncogene addiction in gliomas: Implications for molecular targeted therapy

Oncogene addiction is a phenomenon that the survival of cancer cells depends on an activated oncogene or inactivation of tumor suppressor gene, and is regarded as the 'Achilles heel' of the successful molecular targeted therapies in cancer. However, the role of oncogene addiction in gliomas has not been elucidated systematically. In this review, we summarize the current experimental and clinica...

متن کامل

Oncogene addiction: setting the stage for molecularly targeted cancer therapy.

In pugilistic parlance, the one-two punch is a devastating combination of blows, with the first punch setting the stage and the second delivering the knock-out. This analogy can be extended to molecularly targeted cancer therapies, with oncogene addiction serving to set the stage for tumor cell killing by a targeted therapeutic agent. While in vitro and in vivo examples abound documenting the e...

متن کامل

Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure.

A key goal of cancer therapeutics is to selectively target the genetic lesions that initiate and maintain cancer cell proliferation and survival. While most cancers harbor multiple oncogenic mutations, a wealth of preclinical and clinical data supports that many cancers are sensitive to inhibition of single oncogenes, a concept referred to as 'oncogene addiction'. Herein, we describe the clinic...

متن کامل

Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene

Oncogene addiction describes how cancer cells exhibit dependence on single oncogenes to escape apoptosis and senescence. While oncogene addiction constitutes the basis for new cancer treatment strategies targeting individual kinases and pathways activated by oncogenic mutations, the biochemical basis for this addiction is largely unknown. Here we provide evidence for a metabolic rationale behin...

متن کامل

MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addiction.

UNLABELLED The clinical experience with BCR-ABL tyrosine kinase inhibitors (TKI) for the treatment of chronic myelogenous leukemia (CML) provides compelling evidence for oncogene addiction. Yet, the molecular basis of oncogene addiction remains elusive. Through unbiased quantitative phosphoproteomic analyses of CML cells transiently exposed to BCR-ABL TKI, we identified persistent downregulatio...

متن کامل

An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance.

Although human cancers have complex genotypes and are genomically unstable, they often remain dependent on the continued presence of single-driver mutations-a phenomenon dubbed "oncogene addiction." Such dependencies have been demonstrated in mouse models, where conditional expression systems have revealed that oncogenes able to initiate cancer are often required for tumor maintenance and progr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Current Biology

دوره 22  شماره 

صفحات  -

تاریخ انتشار 2012